Pelvic Floor Function After Obstetric Injury to the Anal Sphincter (PFF)

October 31, 2023 updated by: Sissel Oversand, Oslo University Hospital

The Pelvic Floor Future Study

The goal of this observational study is to learn more about the effect a pregnancy and delivery has on the function of the anal musculature.We will compare women who had a new delivery after suffering a severe tear in the anal musculature in their first pregnancy, with women who had two or more vaginal deliveries, but did not suffer such an injury.

The main questions we want to answer is:

  • can the burden of a new pregnancy and delivery weaken the function of the repaired musculature in a way that might cause symptoms of anal incontinence later in life?
  • can a tear in the anal musculature increase the risk of developing urinary incontinence and long term sexual dysfunction?
  • should we recommend these women to have a caesarian section instead of a new vaginal delivery?

Participants will be asked to complete an electronic questionnaire with information regarding their pregnancies, deliveries and potential symptoms from anal incontinence, urinary incontinence and sexual dysfunction.

Researchers will compare these two groups to find out if a new vaginal delivery has a negative effect on the function of the anal musculature.

Study Overview

Study Type

Observational

Enrollment (Estimated)

900

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Oslo, Norway, 0464
        • Oslo University Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

N/A

Sampling Method

Non-Probability Sample

Study Population

Study population will be women who had two or more vaginal deliveries at Oslo Universitetssykehus in the time period 2002-2018.

Description

Inclusion Criteria:

  • Sphincter group: Previous obstetric anal sphincter injury during vaginal childbirth in 2002-2018 and having a subsequent vaginal delivery without such injury
  • control group: Two or more vaginal deliveries without obstetric anal sphincter injury

Exclusion Criteria:

  • under 18 years
  • consent incompetency
  • Obstetric anal sphincter injury in subsequent pregnancies
  • caesarian section in subsequent pregnancy

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Controls
Women who have had a at least two vaginal deliveries without suffering an injury to the anal sphincter
We will investigate if a new vaginal delivery in those with a previous obstetric anal sphincter injury affects the function of anal musculature negatively
Sphincter damage
Women who suffered an injury to anal sphincter after a vaginal delivery and had a subsequent delivery after this injury
We will investigate if a new vaginal delivery in those with a previous obstetric anal sphincter injury affects the function of anal musculature negatively

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The long-term impact of a new vaginal delivery on anal sphincter function in women with previous obstetric anal sphincter injury.
Time Frame: 5- 20 years
Number of participants with previous OASI who had a new vaginal delivery will be compared to participants with similar parity, without previous OASI. Differences in anal incontinence symptom score and quality of life will be measured by study questionnaires (St. Marks score, PFDI-20 and PFIQ-7).
5- 20 years

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Prevalence of urinary incontinence among women with previous OASI compared to women with similar parity without obstetric anal sphincter injury
Time Frame: 5-20 years
Number of participants who report complaints about urinary incontinence, measured by study questionnaires (PFIQ-7, NFIR, PFDI-20).
5-20 years
The risk of long- term dyspareunia and sexual dysfunction after previous obstetric anal sphincter injury compared to women with similar parity without obstetric anal sphincter injury.
Time Frame: 5-20 years
Number of participants who report complaints about sexual dysfunction, the degree and type og dysfunction will be measured by study questionnaires (PISQ-12)
5-20 years

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Kristine A Kilaas, M.D, Oslo University Hospital
  • Study Director: Rune Svenningsen, Ph.D, Oslo University Hospital
  • Principal Investigator: Sissel Oversand, Oslo University Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 19, 2023

Primary Completion (Estimated)

March 1, 2025

Study Completion (Estimated)

March 1, 2027

Study Registration Dates

First Submitted

March 22, 2023

First Submitted That Met QC Criteria

April 14, 2023

First Posted (Actual)

April 27, 2023

Study Record Updates

Last Update Posted (Actual)

November 2, 2023

Last Update Submitted That Met QC Criteria

October 31, 2023

Last Verified

October 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

The participant data will only be available to the researchers in charge of this project

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Urinary Incontinence

Clinical Trials on Obstetric Anal Sphincter Injury

3
Subscribe